Ayeshia Powell
Acute Care · Atlanta, GANPI 1891164406
Payments from drug & device makers
Across 569 payments — averaging $17.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- UCB, Inc.$818
- Biogen$770
- Lundbeck LLC$560
- Otsuka America Pharmaceutical, Inc.$401
- Argenx US, Inc.$400
- plus $6K from 54 others
What the payments were for
- Food & beverage$10,125100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$10,125 in reported general payments places this provider in the 95th percentile of 679 acute care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 14 | $119,657 |
| VraylarCariprazine Hcl | 16 | $26,552 |
| Trokendi XrTopiramate | 13 | $24,481 |
| Nucynta ErTapentadol Hcl | 11 | $20,697 |
| BelsomraSuvorexant | 28 | $12,546 |
| Aimovig AutoinjectorErenumab-Aooe | 16 | $11,886 |
| Duloxetine Hcl | 225 | $3,609 |
| Gabapentin | 280 | $3,530 |
| Lidocaine | 32 | $3,297 |
| Eletriptan HbrEletriptan Hydrobromide | 11 | $3,167 |
| Lubiprostone | 14 | $2,870 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 113 | $2,644 |
| Lacosamide | 23 | $2,407 |
| Pregabalin | 86 | $2,178 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 79 | $1,733 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,301 | $26,55216 claims |
| Supernus Pharmaceuticals, Inc.Trokendi Xr | $51 | $24,48113 claims |
| Collegium Pharmaceutical, Inc.Nucynta Er | $78 | $20,69711 claims |
| MerckBelsomra | $102 | $12,54628 claims |
| Upsher-smith Laboratories LLCTopiramate | $60 | $54180 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 679 acute care providers in Georgia.
Other acute care in Atlanta
- Sarah WymanAtlanta$10K
- Michael WattsAtlanta$6K
- Merry NevilleAtlanta$5K
- Annalee EdwardsAtlanta$5K
- Jamie ThreattAtlanta$5K
- Kenya RaglandAtlanta$4K
- Emma HallAtlanta$4K
- Gretchen HallAtlanta$4K
- Summer DaviesAtlanta$4K
- Darryl TurnerRinggold$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.